Suppr超能文献

α-和α-肾上腺素受体作为多巴胺和多巴胺受体配体的潜在靶点。

α- and α-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands.

机构信息

Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Triad Technology Building, 333 Cassell Drive, Baltimore, MD, 21224, USA.

Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona, Diagonal 643, 08028, Barcelona, Spain.

出版信息

Mol Neurobiol. 2018 Nov;55(11):8438-8454. doi: 10.1007/s12035-018-1004-1. Epub 2018 Mar 18.

Abstract

The poor norepinephrine innervation and high density of Gi/o-coupled α- and α-adrenoceptors in the striatum and the dense striatal dopamine innervation have prompted the possibility that dopamine could be an effective adrenoceptor ligand. Nevertheless, the reported adrenoceptor agonistic properties of dopamine are still inconclusive. In this study, we analyzed the binding of norepinephrine, dopamine, and several compounds reported as selective dopamine D-like receptor ligands, such as the D receptor agonist 7-OH-PIPAT and the D receptor agonist RO-105824, to α-adrenoceptors in cortical and striatal tissue, which express α-adrenoceptors and both α- and α-adrenoceptors, respectively. The affinity of dopamine for α-adrenoceptors was found to be similar to that for D-like and D-like receptors. Moreover, the exogenous dopamine receptor ligands also showed high affinity for α- and α-adrenoceptors. Their ability to activate Gi/o proteins through α- and α-adrenoceptors was also analyzed in transfected cells with bioluminescent resonance energy transfer techniques. The relative ligand potencies and efficacies were dependent on the Gi/o protein subtype. Furthermore, dopamine binding to α-adrenoceptors was functional, inducing changes in dynamic mass redistribution, adenylyl cyclase activity, and ERK1/2 phosphorylation. Binding events were further studied with computer modeling of ligand docking. Docking of dopamine at α- and α-adrenoceptors was nearly identical to its binding to the crystallized D receptor. Therefore, we provide conclusive evidence that α- and α-adrenoceptors are functional receptors for norepinephrine, dopamine, and other previously assumed selective D-like receptor ligands, which calls for revisiting previous studies with those ligands.

摘要

纹状体中去甲肾上腺素神经支配不良和 Gi/o 偶联的α-和α-肾上腺素能受体密度高,以及纹状体中多巴胺神经支配密集,这促使人们认为多巴胺可能是一种有效的肾上腺素能受体配体。然而,多巴胺的报道的肾上腺素能激动特性仍然不确定。在这项研究中,我们分析了去甲肾上腺素、多巴胺和一些被报道为选择性多巴胺 D 样受体配体的化合物,如 D 受体激动剂 7-OH-PIPAT 和 D 受体激动剂 RO-105824,与皮质和纹状体组织中α-肾上腺素能受体的结合,这些组织分别表达α-肾上腺素能受体和α-和α-肾上腺素能受体。发现多巴胺与α-肾上腺素能受体的亲和力类似于 D 样和 D 样受体。此外,外源性多巴胺受体配体也对α-和α-肾上腺素能受体表现出高亲和力。还通过生物发光共振能量转移技术分析了它们通过α-和α-肾上腺素能受体激活 Gi/o 蛋白的能力。相对配体效力和效率取决于 Gi/o 蛋白亚型。此外,多巴胺与α-肾上腺素能受体的结合是功能性的,可诱导动态质量重分布、腺苷酸环化酶活性和 ERK1/2 磷酸化的变化。通过计算机配体对接模拟进一步研究了结合事件。多巴胺在α-和α-肾上腺素能受体上的对接几乎与其与结晶 D 受体的结合相同。因此,我们提供了确凿的证据表明α-和α-肾上腺素能受体是去甲肾上腺素、多巴胺和其他以前假定的选择性 D 样受体配体的功能性受体,这需要重新审视以前使用这些配体的研究。

相似文献

1
α- and α-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands.
Mol Neurobiol. 2018 Nov;55(11):8438-8454. doi: 10.1007/s12035-018-1004-1. Epub 2018 Mar 18.
5
Selective increase of alpha2A-adrenoceptor agonist binding sites in brains of depressed suicide victims.
J Neurochem. 1998 Mar;70(3):1114-23. doi: 10.1046/j.1471-4159.1998.70031114.x.
7
A study of presynaptic alpha2-autoreceptors in alpha2A/D-, alpha2B- and alpha2C-adrenoceptor-deficient mice.
Naunyn Schmiedebergs Arch Pharmacol. 2001 Aug;364(2):117-30. doi: 10.1007/s002100100423.
8
The C-terminal half of the α2C-adrenoceptor determines the receptor's membrane expression level and drug selectivity.
Naunyn Schmiedebergs Arch Pharmacol. 2013 Dec;386(12):1031-40. doi: 10.1007/s00210-013-0902-z. Epub 2013 Jul 20.

引用本文的文献

2
Progressive noradrenergic degeneration and motor cortical dysfunction in Parkinson's disease.
Acta Pharmacol Sin. 2025 Apr;46(4):829-835. doi: 10.1038/s41401-024-01428-z. Epub 2024 Nov 26.
4
Damage to the Locus Coeruleus Alters the Expression of Key Proteins in Limbic Neurodegeneration.
Int J Mol Sci. 2024 Mar 9;25(6):3159. doi: 10.3390/ijms25063159.
5
Adrenoceptors: A Focus on Psychiatric Disorders and Their Treatments.
Handb Exp Pharmacol. 2024;285:507-554. doi: 10.1007/164_2023_675.
6
7
Dopamine and norepinephrine are embracing their immune side and so should we.
Curr Opin Neurobiol. 2022 Dec;77:102626. doi: 10.1016/j.conb.2022.102626. Epub 2022 Sep 1.
8
Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine.
iScience. 2022 Jul 19;25(8):104771. doi: 10.1016/j.isci.2022.104771. eCollection 2022 Aug 19.
9
Serotonin receptors contribute to dopamine depression of lateral inhibition in the nucleus accumbens.
Cell Rep. 2022 May 10;39(6):110795. doi: 10.1016/j.celrep.2022.110795.
10
Norepinephrine May Oppose Other Neuromodulators to Impact Alzheimer's Disease.
Int J Mol Sci. 2021 Jul 8;22(14):7364. doi: 10.3390/ijms22147364.

本文引用的文献

1
Protocols for Molecular Modeling with Rosetta3 and RosettaScripts.
Biochemistry. 2016 Aug 30;55(34):4748-63. doi: 10.1021/acs.biochem.6b00444. Epub 2016 Aug 16.
2
α2A adrenergic receptors highly expressed in mesoprefrontal dopamine neurons.
Neuroscience. 2016 Sep 22;332:130-9. doi: 10.1016/j.neuroscience.2016.06.037. Epub 2016 Jun 27.
3
Evidence for Noncanonical Neurotransmitter Activation: Norepinephrine as a Dopamine D2-Like Receptor Agonist.
Mol Pharmacol. 2016 Apr;89(4):457-66. doi: 10.1124/mol.115.101808. Epub 2016 Feb 3.
4
BCL::Conf: small molecule conformational sampling using a knowledge based rotamer library.
J Cheminform. 2015 Sep 30;7:47. doi: 10.1186/s13321-015-0095-1. eCollection 2015.
5
Test-retest reliability of (11)C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain.
Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):120-7. doi: 10.1007/s00259-014-2899-z. Epub 2014 Sep 9.
7
G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives.
Pharmacol Rev. 2014 Feb 10;66(2):413-34. doi: 10.1124/pr.113.008052. Print 2014.
8
Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody.
Nature. 2013 Oct 24;502(7472):575-579. doi: 10.1038/nature12572. Epub 2013 Sep 22.
9
High-resolution comparative modeling with RosettaCM.
Structure. 2013 Oct 8;21(10):1735-42. doi: 10.1016/j.str.2013.08.005. Epub 2013 Sep 12.
10
Structural features for functional selectivity at serotonin receptors.
Science. 2013 May 3;340(6132):615-9. doi: 10.1126/science.1232808. Epub 2013 Mar 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验